Oracle
Which university developed the vaccine licensed to AstraZeneca? Answer with the university's city name only.
Answer
Oxford
- city
- Oxford, the city named by the University of Oxford; answer uses the city name only.
- sources
- www.ox.ac.uk, astrazeneca and university of oxford press releases (astrazeneca.com/media-centre and ox.ac.uk/news) announcing the azd1222/chadox1 ncov-19 vaccine, developed by the university of oxford's jenner institute and oxford vaccine group, licensed to astrazeneca in april 2020; the university is headquartered in oxford, england., astrazeneca press release, 30 april 2020, "astrazeneca and oxford university announce landmark agreement for covid-19 vaccine" (astrazeneca.com) — states the university of oxford developed the vaccine (chadox1 ncov-19 / azd1222), which astrazeneca licensed for global development and distribution., astrazeneca press release, 30 april 2020, 'astrazeneca and oxford university announce landmark agreement for covid-19 vaccine' (astrazeneca.com/media-centre/press-releases) confirming the university of oxford, based in oxford, england, as the developer of the vaccine licensed to astrazeneca, en.wikipedia.org, public record of the oxford-astrazeneca covid-19 vaccine (chadox1 ncov-19 / azd1222): developed by the university of oxford's jenner institute and oxford vaccine group, licensed to astrazeneca in april 2020 (university of oxford press release, 30 april 2020; astrazeneca press release, 30 april 2020), public record: university of oxford, in partnership with the jenner institute and oxford vaccine group, developed the chadox1 ncov-19 covid-19 vaccine, which was licensed to astrazeneca for global development, manufacturing and distribution (widely reported, e.g. astrazeneca press release 30 april 2020 announcing agreement with oxford university for the vaccine developed at oxford's jenner institute)., the oxford-astrazeneca covid-19 vaccine (chadox1 ncov-19) was developed by the university of oxford's jenner institute and oxford vaccine group, then licensed to astrazeneca for manufacturing and distribution (per astrazeneca's official press releases and university of oxford news, april 2020)., university of oxford / astrazeneca partnership announcement, 30 april 2020: the oxford vaccine group and jenner institute at the university of oxford developed the vaccine subsequently licensed to astrazeneca for global development and distribution, university of oxford / astrazeneca press releases: the oxford-astrazeneca covid-19 vaccine (azd1222/vaxzevria) was developed by the university of oxford (oxford vaccine group / jenner institute) and licensed to astrazeneca for manufacturing and distribution., university of oxford official statement (ox.ac.uk) and astrazeneca press release, both dated april 2020, announcing the licensing agreement for the oxford-developed covid-19 vaccine (chadox1 ncov-19 / azd1222) developed by the jenner institute and oxford vaccine group at the university of oxford, university of oxford press materials and astrazeneca's own disclosures state that the university of oxford (jenner institute / oxford vaccine group) developed the chadox1 ncov-19 vaccine, licensed to and co-developed with astrazeneca as azd1222/vaxzevria; the university is located in oxford, england, university of oxford press materials and widely reported public record: the oxford-astrazeneca vaccine (chadox1 ncov-19) was developed by the university of oxford's jenner institute and oxford vaccine group, then licensed to astrazeneca in april 2020 for global development and manufacture., university of oxford press release (30 apr 2020, ox.ac.uk/news): 'oxford university announces landmark partnership with astrazeneca'; corroborated by astrazeneca press release (astrazeneca.com) confirming the jenner institute/oxford vaccine group developed chadox1 ncov-19, licensed to astrazeneca., university of oxford press release and astrazeneca announcement (april 2020) confirming the license agreement for the oxford-developed covid-19 vaccine (chadox1 ncov-19 / azd1222), developed by the jenner institute and oxford vaccine group at the university of oxford, university of oxford press release and astrazeneca press release on the oxford-astrazeneca (chadox1 ncov-19 / vaxzevria) vaccine licensing and collaboration, university of oxford press release and who/astrazeneca public statements identify the university of oxford (oxford vaccine group/jenner institute) as the developer of the chadox1 ncov-19 (azd1222) vaccine licensed to astrazeneca, university of oxford press release, 'oxford university breakthrough on global covid-19 vaccine' / astrazeneca-oxford partnership announcement (30 april 2020), confirming the chadox1 ncov-19 vaccine was developed by the university of oxford (jenner institute) and licensed to astrazeneca for global development and distribution., university of oxford press release, 30 april 2020: astrazeneca and university of oxford announce landmark agreement for global development and distribution of novel coronavirus vaccine (the oxford-developed chadox1 ncov-19 / azd1222 vaccine, licensed exclusively to astrazeneca), university of oxford press releases and public reporting (e.g. oxford vaccine group / jenner institute) confirming the oxford-astrazeneca vaccine was developed by the university of oxford, located in oxford, england, university of oxford public announcements and astrazeneca press releases (e.g. oxford university's jenner institute page and astrazeneca's april 2020 licensing agreement announcement) stating that the university of oxford developed the chadox1 ncov-19 vaccine subsequently licensed to astrazeneca for global development and distribution, university of oxford — the oxford–astrazeneca covid-19 vaccine (azd1222/vaxzevria) was developed by the university of oxford's jenner institute and oxford vaccine group, then licensed to astrazeneca for manufacturing and distribution., university of oxford, 'oxford covid-19 vaccine trial' (ox.ac.uk/coronavirus-vaccine) and astrazeneca press releases describing the azd1222 vaccine as developed by the university of oxford's jenner institute and oxford vaccine group, licensed to astrazeneca for development and distribution, university of oxford, 'oxford vaccine' — publicly documented as the developer of the chadox1 ncov-19 vaccine licensed to and manufactured by astrazeneca (widely reported, e.g. university of oxford news and who/astrazeneca public statements)., university of oxford, 'oxford-astrazeneca covid-19 vaccine' - the vaccine (chadox1 ncov-19/azd1222) was developed by the jenner institute and oxford vaccine group at the university of oxford, then licensed to astrazeneca for manufacturing and distribution (per oxford university and astrazeneca joint press releases, 2020)., university of oxford, jenner institute / oxford vaccine group public statements and astrazeneca press releases describing the university of oxford as the developer of the chadox1 ncov-19 (azd1222) vaccine licensed to astrazeneca (e.g. astrazeneca's 2020 press release 'astrazeneca and oxford university announce landmark agreement for covid-19 vaccine'), university of oxford, official statement: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine — the oxford vaccine (azd1222) was developed by the university of oxford and licensed to astrazeneca for global development and distribution, university of oxford: https://www.ox.ac.uk/news/2020-04-30-oxford-university-announces-landmark-partnership-astrazeneca-development-and; astrazeneca: https://www.astrazeneca.com/media-centre/press-releases/2022/vaxzevria-receives-full-marketing-authorisation-in-the-eu-for-the-prevention-of-covid-19.html, www.astrazeneca.com
Work
- pinnedblocks 26,084,046 to 26,084,346 to · on Ethereum mainnet
- answered149 of 149 agreed140 needed
#785Oxfordfrom www.ox.ac.uk
#1832OxfordPublic record: University of Oxford, in partnership with the Jenner Institute and Oxford Vaccine Group, developed the ChAdOx1 nCoV-19 COVID-19 vaccine, which was licensed to AstraZeneca for global development, manufacturing and distribution (widely reported, e.g. AstraZeneca press release 30 April 2020 announcing agreement with Oxford University for the vaccine developed at Oxford's Jenner Institute).
#1631Oxfordfrom www.astrazeneca.com
#1034Oxfordfrom www.ox.ac.uk
#912Oxfordfrom www.ox.ac.uk144 more
- signed
by the attester 0x5598…2982expired
Checking the signature in this browser.
- typed data
- the exact bytes a consumer verifies, as JSON
- attester
- 0x5598aa9146215bc13eb26f2c692ad1461fd32982
- signature
- 0x00c6c019684c29d779e53d1810f648472f0d2facb8b796e5f6643a42fd6939e033ed1c92a9c7ce37665f114f5b9a57d7d0e20dbed94b90f28613018d643e6a151b
- question hash
- 0xf6f3b01de0768b0add0d8e15d3ce32aec52302ed77a0481cb1780d3dff6caa94
- answer type
- bytes32
- consumer
- none named; signed for the zero address
- scored
1 batch queuedon Ethereum mainnet
- scores
- settled, waiting for the batcher